Atp-hydrolyzing enzyme useful for treating dysbiosis
The present invention provides an ATP hydrolyzing enzyme, a nucleic acid encoding an ATP hydrolyzing enzyme, or host cells, microorganisms, such as bacteria, or viral particles comprising such nucleic acids encoding an ATP hydrolyzing enzyme for use in the treatment of dysbiosis or a dysbiosis-related disease..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Europäisches Patentamt - (2022) vom: 08. Dez. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
GRASSI FABIO [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-12-08, Last update posted on www.tib.eu: 2023-07-24, Last updated: 2023-07-28 |
|---|
| Patentnummer: |
AU2021288920 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA017136784 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA017136784 | ||
| 003 | DE-627 | ||
| 005 | 20230728091515.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230614s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA017136784 | ||
| 035 | |a (EPA)AU2021288920 | ||
| 035 | |a (EPA)71103358 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a GRASSI FABIO |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Atp-hydrolyzing enzyme useful for treating dysbiosis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2022-12-08, Last update posted on www.tib.eu: 2023-07-24, Last updated: 2023-07-28 | ||
| 520 | |a The present invention provides an ATP hydrolyzing enzyme, a nucleic acid encoding an ATP hydrolyzing enzyme, or host cells, microorganisms, such as bacteria, or viral particles comprising such nucleic acids encoding an ATP hydrolyzing enzyme for use in the treatment of dysbiosis or a dysbiosis-related disease. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a PERRUZZA LISA |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 08. Dez. |
| 773 | 1 | 8 | |g year:2022 |g day:08 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/71103358/publication/AU2021288920A1?q=AU2021288920 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2022 |b 08 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2022 |b 08 |c 12 | ||